Trial ID or NCT#

NCT01619085

Status

NOT RECRUITING

Purpose

The aim of this extension trial is to assess the long-term safety of BIBF 1120 treatment in patients with Idiopathic Pulmonary Fibrosis who have completed one year treatment and the follow up period in the double-blind phase III placebo controlled parent trials (1199.32 and 1199.34), who wish to continue treatment with BIBF 1120.

 

Investigator(s)

Contact us to find out if this trial is right for you.

CONTACT

Rosemary Vojnik
(650) 723-7409